CFHR3 and hemolytic-uremic syndrome: Moreover, although a complete homozygous deletion of CFHR1 and CFHR3 is not by itself considered pathogenic, it can be considered a risk factor for the development of HUS, and in the majority of cases it is associated with production of anti-factor H antibodies, as occurred in one of our patients16,17.